220 related articles for article (PubMed ID: 27764176)
21. Insulinotropic activity of the imidazoline derivative RX871024 in the diabetic GK rat.
Efanov AM; Appelskog IB; Abdel-Halim SM; Khan A; Bränström R; Larsson O; Ostenson CG; Mest HJ; Berggren PO; Efendic S; Zaitsev SV
Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E117-24. PubMed ID: 11739091
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological approach to understanding the control of insulin secretion in human islets.
Henquin JC; Dufrane D; Gmyr V; Kerr-Conte J; Nenquin M
Diabetes Obes Metab; 2017 Aug; 19(8):1061-1070. PubMed ID: 28116849
[TBL] [Abstract][Full Text] [Related]
23. Optical control of insulin release using a photoswitchable sulfonylurea.
Broichhagen J; Schönberger M; Cork SC; Frank JA; Marchetti P; Bugliani M; Shapiro AM; Trapp S; Rutter GA; Hodson DJ; Trauner D
Nat Commun; 2014 Oct; 5():5116. PubMed ID: 25311795
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
Kramer W; Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
[TBL] [Abstract][Full Text] [Related]
25. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
[TBL] [Abstract][Full Text] [Related]
26. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
Sato Y; Anello M; Henquin JC
Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
[TBL] [Abstract][Full Text] [Related]
27. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.
Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249
[TBL] [Abstract][Full Text] [Related]
28. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I
J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109
[TBL] [Abstract][Full Text] [Related]
29. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells.
Eliasson L; Renström E; Ammälä C; Berggren PO; Bertorello AM; Bokvist K; Chibalin A; Deeney JT; Flatt PR; Gäbel J; Gromada J; Larsson O; Lindström P; Rhodes CJ; Rorsman P
Science; 1996 Feb; 271(5250):813-5. PubMed ID: 8628999
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
[TBL] [Abstract][Full Text] [Related]
31. Glucose-induced insulin secretion is potentiated by a new imidazoline compound.
Mest HJ; Raap A; Schloos J; Treinies I; Paal M; Giese U; Koivisto V
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):47-52. PubMed ID: 11485038
[TBL] [Abstract][Full Text] [Related]
32. [Molecular mechanisms of insulin secretion].
Bataille D
Diabetes Metab; 2002 Dec; 28(6 Suppl):4S7-13. PubMed ID: 12703060
[TBL] [Abstract][Full Text] [Related]
33. Glibenclamide inhibits islet carnitine palmitoyltransferase 1 activity, leading to PKC-dependent insulin exocytosis.
Lehtihet M; Welsh N; Berggren PO; Cook GA; Sjoholm A
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E438-46. PubMed ID: 12684219
[TBL] [Abstract][Full Text] [Related]
34. Polysaccharide isolated from Triticum aestivum stimulates insulin release from pancreatic cells via the ATP-sensitive K+ channel.
Lee SH; Lim SW; Lee YM; Lee HS; Kim DK
Int J Mol Med; 2012 May; 29(5):913-9. PubMed ID: 22322245
[TBL] [Abstract][Full Text] [Related]
35. In vitro effects of bis(1,2-dimethyl-3-hydroxy-4-pyridinonato)oxidovanadium(IV), or VO(dmpp)2, on insulin secretion in pancreatic islets of type 2 diabetic Goto-Kakizaki rats.
Pelletier J; Domingues N; Castro MM; Östenson CG
J Inorg Biochem; 2016 Jan; 154():29-34. PubMed ID: 26559485
[TBL] [Abstract][Full Text] [Related]
36. Molecular action of sulphonylureas on KATP channels: a real partnership between drugs and nucleotides.
de Wet H; Proks P
Biochem Soc Trans; 2015 Oct; 43(5):901-7. PubMed ID: 26517901
[TBL] [Abstract][Full Text] [Related]
37. Structural nucleotide analogs are potent activators/inhibitors of pancreatic β cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs.
Tricarico D; Rolland JF; Cannone G; Mele A; Cippone V; Laghezza A; Carbonara G; Fracchiolla G; Tortorella P; Loiodice F; Conte Camerino D
J Pharmacol Exp Ther; 2012 Feb; 340(2):266-76. PubMed ID: 22028392
[TBL] [Abstract][Full Text] [Related]
38. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
Marble A
Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
[No Abstract] [Full Text] [Related]
39. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
40. Suppression of KATP channel activity protects murine pancreatic beta cells against oxidative stress.
Gier B; Krippeit-Drews P; Sheiko T; Aguilar-Bryan L; Bryan J; Düfer M; Drews G
J Clin Invest; 2009 Nov; 119(11):3246-56. PubMed ID: 19805912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
